Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 6
542
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Bromhexine and its inhibitory effect on lipase – kinetics and structural study

, ORCID Icon &
Pages 1687-1692 | Received 06 Jun 2020, Accepted 23 Jun 2020, Published online: 07 Jul 2020

References

  • Bever, R.A. and Iglewski, B.H., 1988. Molecular characterization and nucleotide sequence of the Pseudomonas aeruginosa elastase structural gene. Journal of bacteriology, 170 (9), 4309–4314.
  • Böttcher, E., et al., 2006. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of virology, 80 (19), 9896–9898.
  • Buisman, G.J.H., et al., 1998. Enzymatic esterifications of functionalized phenols for the synthesis of lipophilic antioxidants. Biotechnology letters, 20 (2), 131–136.
  • Cryz, S.J. and Iglewski, B.H., 1980. Production of alkaline protease by Pseudomonas aeruginosa. Journal of clinical microbiology, 12 (1), 131–133.
  • de Bentzmann, S. and Plesiat, P., 2011. The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environmental microbiology, 13 (7), 1655–1665.
  • Depfenhart, M., et al., 2020. Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy? Internal and emergency medicine.
  • Ellis, G. P. and West, G. B., 1970. Progress in medicinal chemistry. Vol. 7. London, UK: Butterworth & Co Pub., 44–45.
  • Felix, K., Pairet, M., and Zimmermann, R., 1996. The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-l-cysteine. A pulse radiolysis study. Life sciences, 59 (14), 1141–1147.
  • Frimmersdorf, E., et al., 2010. How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach. Environmental microbiology, 12 (6), 1734–1747.
  • Hafez, M.M., et al., 2009. Activity of some mucolytics against bacterial adherence to mammalian cells. Applied biochemistry and biotechnology, 158 (1), 97–112.
  • Iwata-Yoshikawa, N., et al., 2019. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. Journal of virology, 93, e01815–e01818.
  • Lucas, J.M., et al., 2014. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer discovery, 4 (11), 1310–1325.
  • Lyczak, J.B., Cannon, C.L., and Pier, G.B., 2002. Lung infections associated with cystic fibrosis. Clinical microbiology reviews, 15 (2), 194–222.
  • Maggio, R. and Corsini, G.U., 2020. Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection. Pharmacological research, 157, 104837.
  • Masoud, M., Ebrahimi, F., and Minai-Tehrani, D., 2014. Effect of cimetidine on catalase activity of Pseudomonas aeruginosa: a suggested mechanism of action. Journal of molecular microbiology and biotechnology, 24 (3), 196–201.
  • Matsumae, H., Furui, M., and Shibatani, T., 1993. Lipase catalysed asymmetric hydrolysis of 3-phenylglycidic acid ester, the key intermediate in the synthesis of Ditiazem hydrochoride. Journal of fermentation and bioengineering, 75 (2), 93–98.
  • Minai-Tehrani, D., et al., 2011. Inhibition of renal alkaline phosphatase by cimetidine. Drug metabolism letters, 5 (3), 197–201.
  • Olivieri, D., et al., 1991. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo. Respiration; international review of thoracic diseases, 58 (3–4), 117–121.
  • Ostroff, R.M. and Vasil, M.L., 1987. Identification of a new phospholipase C activity by analysis of an insertional mutation in the hemolytic phospholipase C structural gene of Pseudomonas aeruginosa. Journal of bacteriology, 169 (10), 4597–4601.
  • Pollack, M., 2000. Streptococcus pneumonia. In: G.L. Mandell, J.E. Bennet, and R. Dolin, eds. Principles and practice of infectious diseases. Vol. 2. Philadelphia, PA: Churchill Livingstone, 2310–2335.
  • Rubin, B. and Dennis, E.A., 1997. Lipases: part A. Biotechnology methods in enzymology. Vol. 284. New York, NY: Academic Press, 1–408.
  • Sergent, T., et al., 2012. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food chemistry, 135 (1), 68–73.
  • Stuer, W., Jaeger, K.E., and Winkler, U.K., 1986. Purification of extracellular lipase from Pseudomonas aeruginosa. Journal of bacteriology, 168 (3), 1070–1074.
  • Talebi, M., et al., 2018. Inhibitory action of dicyclomine on lipase activity, kinetics and molecular study. International Journal of biological macromolecules, 107 (Part B), 2422–2428.
  • Vulfson, E. N., 1994. Industrial Applications of Lipases. In: P. Woolley and S.B. Peterson, eds., Lipases – their structure, biochemistry and application. Cambridge, UK: Cambridge University Press, 271–288.
  • Yazdi, F., et al., 2015. Functional and structural changes of human erythrocyte catalase induced by cimetidine: proposed model of binding. Molecular and cellular biochemistry, 404 (1–2), 97–102.
  • Zhi, J., et al., 1995. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. Journal of clinical pharmacology, 35 (11), 1103–1108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.